companydata.dkInnosurge Biologics A/S: Financial statements 2018
CVR: 38768964
Innosurge Biologics A/S (CVR 38768964) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,740,667 and a net result of DKK 799,342. Equity amounted to DKK 1,759,891. The solvency ratio was 35.2%. The company had 1 employee in the financial year.
- Gross Profit
- 1,740,667 kr.
- Profit/Loss
- 799,342 kr.
- Equity
- 1,759,891 kr.
- Total Assets
- 5,005,606 kr.
- Employees
- 1
Keep an eye on Innosurge Biologics A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
Innosurge Biologics A/S has published its interim report for the period June 23, 2017 – December 31, 2017.
About Innosurge Biologics A/S
Innosurge Biologics A/S is a Danish company of the type Aktieselskab based in Randers NV, founded in 2017. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Peter Møller Lassen. The company is owned by CMA HOLDING RANDERS ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 4,455,235 and a net result of DKK 1,662,593 compared with DKK 251,617 the year before. Equity amounted to DKK 2,897,096.